INPOMIAN Trademark

Trademark Overview


On Thursday, October 8, 2015, a trademark application was filed for INPOMIAN with the United States Patent and Trademark Office. The USPTO has given the INPOMIAN trademark a serial number of 86782497. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 11, 2017. This trademark is owned by Eli Lilly and Company. The INPOMIAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutic...
inpomian

General Information


Serial Number86782497
Word MarkINPOMIAN
Filing DateThursday, October 8, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 11, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, pancreatic diseases and disorders, Parkinson's disease, psychiatric disorders, sleep disorders, urological disorders; antidepressants; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 14, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, September 11, 2017ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 11, 2017ABANDONMENT - NO USE STATEMENT FILED
Thursday, March 9, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 9, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 26, 2017EXTENSION 2 GRANTED
Thursday, January 26, 2017EXTENSION 2 FILED
Thursday, January 26, 2017TEAS EXTENSION RECEIVED
Friday, August 5, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 4, 2016EXTENSION 1 GRANTED
Thursday, June 30, 2016EXTENSION 1 FILED
Monday, August 1, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 30, 2016TEAS EXTENSION RECEIVED
Tuesday, February 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 15, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 25, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, November 4, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 30, 2015ASSIGNED TO EXAMINER
Wednesday, October 14, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, October 12, 2015NEW APPLICATION ENTERED IN TRAM